US approval for kidney tumor ablation platform

Israel’s Techsomed (see here previously) has received US FDA approval for its BioTraceIO360 software platform to be used to burn or freeze kidney tumors. The device was previously approved only for destroying liver tumors.

https://evtoday.com/news/techsomeds-biotraceio360-platform-cleared-for-kidney-ablation-indication

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *